Back to Search
PRISCILLA HOLLANDER, PH.D, M.D.
PH.D, M.D.
Endocrinology, Diabetes & Metabolism Physician
NPI: 1417988098IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
E7985(TX)
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
E7985(TX)
CMS Specialties
PrimaryENDOCRINOLOGY
Education
HARVARD MEDICAL SCHOOL
Class of 1974
Research & Publications (20)
A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.
PMID 19108786·Clin Ther·2008
4-observational
Low-dose rosiglitazone in patients with insulin-requiring type 2 diabetes.
PMID 17592102·Arch Intern Med·2007
4-observational
Body weight changes associated with insulin therapy: a retrospective pooled analysis of inhaled human insulin (Exubera) versus subcutaneous insulin in five controlled Phase III trials.
PMID 17536080·Diabetes Care·2007
3-trial
Evolution of a pulmonary insulin delivery system (Exubera) for patients with diabetes.
PMID 17435648·MedGenMed·2007
6-review
Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus.
PMID 17296341·Am J Med·2007
4-observational
Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients.
PMID 15090634·Obes Res·2004
3-trial
Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial.
PMID 15451900·Diabetes Care·2004
3-trial
Addition of pramlintide to insulin therapy lowers HbA1c in conjunction with weight loss in patients with type 2 diabetes approaching glycaemic targets.
PMID 14617226·Diabetes Obes Metab·2003
1-meta
Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial.
PMID 12610038·Diabetes Care·2003
3-trial
Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetes.
PMID 11375357·Diabetes Care·2001
3-trial
Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes.
PMID 18535196·Diabetes Care·2008
2-rct
Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial.
PMID 18824271·Diabetes Res Clin Pract·2008
2-rct
Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine.
PMID 18364392·Diabetes Care·2008
4-observational
SERENADE: the Study Evaluating Rimonabant Efficacy in Drug-naive Diabetic Patients: effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes.
PMID 18678611·Diabetes Care·2008
2-rct
A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients.
PMID 17363756·Diabetes Care·2007
4-observational
Basal insulin or premix analogue therapy in type 2 diabetes patients.
PMID 17223044·Eur J Intern Med·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3600 GASTON AVE, SUITE 656, WADLEY TOWER
DALLAS, TX 75246 - Phone
- (214) 820-3466
Quick Facts
- NPI
- 1417988098
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 52
- Publications
- 20
Are you this provider?
Claim Your Profile